Association of inflammatory gene polymorphisms with ischemic stroke in a Chinese Han population

Journal of Neuroinflammation

Volumn 9, Issue , 2012, Pages

  Zhao, Nan ^a   Liu, Xin ^b,c   Wang, Yongqin ^b   Liu, Xiaoqiu ^a   Li, Jiana ^a   Yu, Litian ^d   Ma, Liyuan ^d   Wang, Shuyu ^b   Zhang, Hongye ^b   Liu, Lisheng ^b   Zhao, Jingbo ^a   Wang, Xingyu ^b,c  

^a HARBIN MEDICAL UNIVERSITY   (China)

^b Beijing Hypertension League Institute   (China)

^c SHANTOU UNIVERSITY MEDICAL COLLEGE   (China)

^d FUWAI HOSPITAL   (China)

Author keywords

Association study; Hypertension; Inflammatory gene; Ischemic stroke

Indexed keywords

CHEMOKINE RECEPTOR CCR2; CHEMOKINE RECEPTOR CCR5; CXCL11 CHEMOKINE; EOTAXIN; LEUKOTRIENE C4 SYNTHASE; LYMPHOTOXIN; TRANSFORMING GROWTH FACTOR BETA1;

ADULT; ARTICLE; BLOOD PRESSURE; BRAIN ISCHEMIA; CHEMOKINE LIGAND 11 GENE; CHEMOKINE RECEPTOR 2 GENE; CHEMOKINE RECEPTOR 5 GENE; CHINESE; CONTROLLED STUDY; DISEASE ASSOCIATION; FC EPSILON RI BETA GENE; FEMALE; GENE; GENETIC ASSOCIATION; GENETIC RISK; GENETIC SCREENING; GENETIC VARIABILITY; GENOTYPE; HUMAN; HYPERTENSION; LEUKOTRIENE C4 SYNTHASE GENE; LYMPHOTOXIN ALPHA GENE; MAJOR CLINICAL STUDY; MALE; POPULATION GENETICS; SINGLE NUCLEOTIDE POLYMORPHISM; TRANSFORMING GROWTH FACTOR BETA1 GENE;

EID: 84863449055     PISSN: None     EISSN: 17422094     Source Type: Journal    
DOI: 10.1186/1742-2094-9-162     Document Type: Article

References (35)

1. Bonita R, Mendis S, Truelsen T, Bogousslavsky J, Toole J, Yatsu F. The global stroke initiative. Lancet Neurol 2004, 3:391.
2. Zhang LF, Yang J, Hong Z, Yuan GG, Zhou BF, Zhao LC, Huang YN, Chen J, Wu YF. Proportion of different subtypes of stroke in China. Stroke 2003, 34:2091-2096.
3. O'Donnell MJ, Xavier D, Liu L, Zhang H, Chin SL, Rao-Melacini P, Rangarajan S, Islam S, Pais P, McQueen MJ. Risk factors for ischaemic and intracerebral haemorrhagic stroke in 22 countries (the INTERSTROKE study): a case-control study. Lancet 2010, 376:112-123.
4. Muir KW, Tyrrell P, Sattar N, Warburton E. Inflammation and ischaemic stroke. Curr Opin Neurol 2007, 20:334.
5. Flex A, Gaetani E, Papaleo P, Straface G, Proia AS, Pecorini G, Tondi P, Pola P, Pola R. Proinflammatory genetic profiles in subjects with history of ischemic stroke. Stroke 2004, 35:2270-2275.
6. Zee RYL, Ridker PM. Polymorphism in the human C-reactive protein (CRP) gene, plasma concentrations of CRP, and the risk of future arterial thrombosis. Atherosclerosis 2002, 162:217-219.
7. Yoshida M, Takano Y, Sasaoka T, Izumi T, Kimura A. E-selectin polymorphism associated with myocardial infarction causes enhanced leukocyte-endothelial interactions under flow conditions. Arterioscler Thromb Vasc Biol 2003, 23:783-788.
8. Rubattu S, Volpe M, Kreutz R, Ganten U, Ganten D, Lindpaintner K. Chromosomal mapping of quantitative trait loci contributing to stroke in a rat model of complex human disease. Nat Genet 1996, 13:429-434.
9. Wang X, Cheng S, Brophy VH, Erlich HA, Mannhalter C, Berger K, Lalouschek W, Browner WS, Shi Y, Ringelstein EB. A meta-analysis of candidate gene polymorphisms and ischemic stroke in 6 study populations. Association of lymphotoxin-alpha in nonhypertensive patients. Stroke 2009, 108:524587-v524581. STROKEAHA.
10. Cordell HJ, Clayton DG. Genetic association studies. Lancet 2005, 366:1121-1131.
11. Benjamini Y, Hochberg Y. Controlling the false discovery rate: a practical and powerful approach to multiple testing. Journal of the Royal Statistical Society Series B (Methodological) 1995, 289-300.
12. Smith NL, Hindorff LA, Heckbert SR, Lemaitre RN, Marciante KD, Rice K, Lumley T, Bis JC, Wiggins KL, Rosendaal FR. Association of genetic variations with nonfatal venous thrombosis in postmenopausal women. JAMA 2007, 297:489.
13. Arboix A, Roig H, Rossich R, Martinez E, Garc-Eroles L. Differences between hypertensive and non-hypertensive ischemic stroke. Eur J Neurol 2004, 11:687-692.
14. Nakamura H, Luster AD, Nakamura T, In KH, Sonna LA, Deykin A, Israel E, Drazen JM, Lilly CM. Variant eotaxin: its effects on the asthma phenotype. J Allergy Clin Immunol 2001, 108:946-953.
15. Farahi N, Cowburn AS, Upton PD, Deighton J, Sobolewski A, Gherardi E, Morrell NW, Chilvers ER. Eotaxin-1/CC chemokine ligand 11: a novel eosinophil survival factor secreted by human pulmonary artery endothelial cells. J Immunol 2007, 179:1264.
16. Colobran R, Pujol-Borrell R, Armengol M, Juan M. The chemokine network. II. On how polymorphisms and alternative splicing increase the number of molecular species and configure intricate patterns of disease susceptibility. Clin Exp Immunol 2007, 150:1-12.
17. Haley KJ, Lilly CM, Yang JH, Feng Y, Kennedy SP, Turi TG, Thompson JF, Sukhova GH, Libby P, Lee RT. Overexpression of eotaxin and the CCR3 receptor in human atherosclerosis: using genomic technology to identify a potential novel pathway of vascular inflammation. Circulation 2000, 102:2185.
18. Kodali RB, Kim WJH, Galaria II, Miller C, Schecter AD, Lira SA, Taubman MB. CCL11 (Eotaxin) induces CCR3-dependent smooth muscle cell migration. Arterioscler Thromb Vasc Biol 2004, 24:1211-1216.
19. Cheng SS, Lukacs NW, Kunkel SL. Eotaxin/CCL11 suppresses IL-8/CXCL8 secretion from human dermal microvascular endothelial cells. J Immunol 2002, 168:2887.
20. Ortlepp JR, Vesper K, Mevissen V, Schmitz F, Janssens U, Franke A, Hanrath P, Weber C, Zerres K, Hoffmann R. Chemokine receptor(CCR 2) genotype is associated w it h myo-cardial infarction and heart failure in pa-tients under 65 years of age. J Mol Med 2003, 81:363-367.
21. Petrkova J, Cermakova Z, Drabek J, Lukl J, Petrek M. CC chemokine receptor (CCR)2 polymorphism in Czech patients with myo-cardial infarction. Immunol Lett 2003, 88:53-55.
22. Nyquist PA, Winkler CA, McKenzie LM, Yanek LR, Becker LC, Becker DM. Single nucleotide polymorphisms in monocyte chemoattractant protein-1 and its receptor act synergistically to increase the risk of carotid atherosclerosis. Cerebrovasc Dis 2009, 28(2):124-130.
23. Dimitrijevic OB, Stamatovic SM, Keep RF, Andjelkovic AV. Absence of the chemokine receptor CCR2 protects against cerebral ischemia/reperfusion injury in mice. Stroke 2007, 38:1345-1353.
24. Mooyaart AL, Valk EJJ, van LA E, Bruijn JA, de Heer E, Freedman BI, Dekkers OM, Baelde HJ. Genetic associations in diabetic nephropathy: a meta-analysis. Diabetologia 2011, 54:544-553.
25. Terao S, Yilmaz G, Stokes KY, Russell J, Ishikawa M, Kawase T, Granger DN. Blood cell-derived RANTES mediates cerebral microvascular dysfunction, inflammation, and tissue injury after focal ischemia Creperfusion. Stroke 2008, 39:2560-2570.
26. Mirabelli-Badenier M, Braunersreuther V, Viviani GL, Dallegri F, Quercioli A, Veneselli E, Mach F, Montecucco F. CC and CXC chemokines are pivotal mediators of cerebral injury in ischaemic stroke. Thromb Haemost 2011, 105:105.
27. Sie MPS, Uitterlinden AG, Bos MJ, Arp PP, Breteler M, Koudstaal PJ, Pols HAP, Hofman A, van Duijn CM, Witteman J. TGF-{beta}1 polymorphisms and risk of myocardial infarction and stroke. Stroke 2006, 37:2667-2671.
28. Iovannisci DM, Lammer EJ, Steiner L, Cheng S, Mahoney LT, Davis PH, Lauer RM, Burns TL. Association between a leukotriene C4 synthase gene promoter polymorphism and coronary artery calcium in young women. Arterioscler Thromb Vasc Biol 2007, 27:394-399.
29. Hoppe C, Klitz W, D'Harlingue K, Cheng S, Grow M, Steiner L, Noble J, Adams R, Styles L. Confirmation of an association between the TNF (-308) promoter polymorphism and stroke risk in children with sickle cell anemia. Stroke 2007, 107:483115-v483111. STROKEAHA.
30. Cui T, Wang L, Wu J, Xie J. The association analysis of FcepsilonRIbeta with allergic asthma in a Chinese population. Chin Med J (Engl) 2003:116.
31. Nikol S, Isner JM, Pickering JG, Kearney M, Leclerc G, Weir L. Expression of transforming growth factor-1 is increased in human vascular restenosis lesions. J Clin Invest 1992, 90:1582-1592.
32. Schulick AH, Taylor AJ, Zuo W, Qiu CB, Dong G, Woodward RN, Agah R, Roberts AB, Virmani R, Dichek DA. Overexpression of transforming growth factor- β1 in arterial endothelium causes hyperplasia, apoptosis, and cartilaginous metaplasia. Proc Natl Acad Sci U S A 1998, 95:6983-6988.
33. Donnadieu E, Jouvin MH, Kinet JP. A second amplifier function for the allergy-associated Fc(ε{lunate})RI- β subunit. Immunity 2000, 12:515-523.
34. Savoia C, Schiffrin EL. Inflammation in hypertension. Curr Opin Nephrol Hypertens 2006, 15:152.
35. Cachofeiro V, Miana M, Martin-Fernandez B, Ballesteros S, Balfagon G, Laher V. Inflammation: a link between hypertension and atherosclerosis. Current Hypertension Reviews 2009, 5:40-48.